Please login to the form below

Not currently logged in


This page shows the latest sirukumab news and features for those working in and with pharma, biotech and healthcare.

FDA wants more data on J&J’s arthritis drug Plivensia

FDA wants more data on J&J’s arthritis drug Plivensia

Depending on the scale of the trial needed, J&J could face a considerable delay before it can bring Plivensia (sirukumab) to market, dampening the commercial prospects for the drug and ... J&J sought approval of sirukumab as a treatment for adults with

Latest news

More from news
Approximately 7 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Opening up innovation Opening up innovation

    Looking to some of GSK's other pipeline highlights, Paul-Peter points to its anti-interleukin-6 antibody sirukumab, which was filed with European regulators for rheumatoid arthritis last month.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...